Adma Biologics reported 15.02 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Adma Biologics 15.02 14.71 Mar/2026
Alnylam Pharmaceuticals 75.64 4.4 Jun/2026
BioCryst Pharmaceuticals 6.84 0.78 Jun/2026
Novavax 2.01 1.07 Dec/2025
Takeda 24.4 22.12 Jun/2026